Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 8;12(8):e060632.
doi: 10.1136/bmjopen-2021-060632.

Long-term outcomes following antenatal exposure to low-dose aspirin: study protocol for the 4-year follow-up of the APRIL randomised controlled trial

Anadeijda J E M C Landman  1   2 , Emilie V J van Limburg Stirum  2   3 , Janneke van 't Hooft  2   3 , Aleid G Leemhuis  4 , Martijn J J Finken  5 , Anneloes L van Baar  6 , Tessa J Roseboom  2   3   7 , Anita C J Ravelli  8 , Madelon van Wely  2   3 , Jaap Oosterlaan  2   4   9 , Rebecca C Painter  2   3 , Eva Pajkrt  2   3 , Martijn A Oudijk  2   3 , Marjon A de Boer  10   2
Affiliations

Long-term outcomes following antenatal exposure to low-dose aspirin: study protocol for the 4-year follow-up of the APRIL randomised controlled trial

Anadeijda J E M C Landman et al. BMJ Open. .

Abstract

Introduction: The use of low-dose aspirin by pregnant women to prevent preterm pre-eclampsia is gradually increasing. The administration of aspirin during pregnancy improves perinatal outcome, which could translate into improved child outcome in the long term. However, antenatal exposure to aspirin could have adverse effects on child development that may manifest later in life. The aim of this follow-up study is to assess the long-term effects of antenatal exposure to low-dose aspirin compared with placebo on survival, (neuro)development, behaviour and general health at 4 years corrected age.

Methods and analysis: This is a follow-up study of the Dutch double-blind randomised controlled APRIL trial which assessed the effectiveness of treatment with aspirin (80 mg daily) compared with placebo for the prevention of preterm birth in women with a previous spontaneous preterm birth. Treatment was initiated before 16 weeks of gestation and continued until 36 weeks or birth. We aim to follow-up all 379 children born to women who participated in the APRIL trial and survived the neonatal period, at the corrected age of 4 years. The main outcomes are (neuro)development as assessed by the Ages and Stages Questionnaire, and behaviour as assessed by the Strength and Difficulties Questionnaire. Additional outcomes include mortality, growth and general health from birth up to 4 years, and a composite outcome including mortality, abnormal (neuro)development and problem behaviour. Analyses will be performed by intention-to-treat using a superiority design.

Ethics and dissemination: Institutional Review Board approval was obtained from the Medical Research Ethics Committee from Amsterdam Medical Center (no. W20 289#20.325). The results will be published in a peer-reviewed journal and presented at conferences.

Trial registration number: The APRIL trial (NTR5675, NL5553; EudraCT number 2015-003220-31) and the APRIL follow-up study (NL8950) are registered in the Dutch trial register. The study is funded by the Amsterdam Reproduction & Development research institute.

Keywords: EPIDEMIOLOGY; Fetal medicine; Maternal medicine; PAEDIATRICS; PERINATOLOGY.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flow diagram of participants eligible for follow-up.
Figure 2
Figure 2
Tracing and contact mechanisms of eligible participants.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Duley L, Meher S, Hunter KE, et al. . Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2019;2019. 10.1002/14651858.CD004659.pub3 - DOI - PMC - PubMed
    1. Hoffman MK, Goudar SS, Kodkany BS, et al. . Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (aspirin): a randomised, double-blind, placebo-controlled trial. The Lancet 2020;395:285–93. 10.1016/S0140-6736(19)32973-3 - DOI - PMC - PubMed
    1. National Institute for Health and Care Excellence . Hypertension in pregnancy: diagnosis and management (NICE guideline 133, 2011. Available: https://www.nice.org.uk/guidance/ng133 - PubMed
    1. Ayala NK, Rouse DJ. A Nudge toward universal aspirin for preeclampsia prevention. Obstet Gynecol 2019;133:725–8. 10.1097/AOG.0000000000003167 - DOI - PubMed
    1. Jacobson RL, Brewer A, Eis A, et al. . Transfer of aspirin across the perfused human placental cotyledon. Am J Obstet Gynecol 1991;165:939–44. 10.1016/0002-9378(91)90444-V - DOI - PubMed

Publication types

Substances

LinkOut - more resources